We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
-7.52%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$250M
AUM Growth
-$48.9M
Cap. Flow
-$2.79M
Cap. Flow %
-1.12%
Top 10 Hldgs %
27.41%
Holding
148
New
29
Increased
17
Reduced
14
Closed
22

Top Buys

Rank Stock Value
1
PEPL
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
+$7.25M
2
GH icon
Guardant Health
GH
+$5.2M
3
STAA icon
STAAR Surgical
STAA
+$4.83M
4
INGN icon
Inogen
INGN
+$4.14M
5
CCXI
ChemoCentryx, Inc.
CCXI
+$3.53M

Top Sells

Rank Stock Value
1
ESPR
Esperion Therapeutics
ESPR
+$7.56M
2
PEPLU
PepperLime Health Acquisition Corporation Unit
PEPLU
+$7.23M
3
GMED icon
Globus Medical
GMED
+$5.83M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$5.82M
5
BCYC
Bicycle Therapeutics
BCYC
+$5.27M

Sector Composition

Rank Sector Weight
1 Healthcare 73.54%
2 Financials 11.69%
3 Industrials 1.28%
4 Technology 0.99%
5 Consumer Discretionary 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLSA
76
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$990K 0.4%
100,000
– –
OMEG
77
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$985K 0.39%
100,000
– –
OHAA
78
DELISTED
OPY Acquisition Corp. I Class A Common Stock
OHAA
$984K 0.39%
100,000
– –
ARYD
79
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$981K 0.39%
100,000
– –
FATBW
80
DELISTED
FAT Brands Inc. Warrant
FATBW
$965K 0.39%
227,000
– –
HLLY icon
81
Holley
HLLY
$362M
$840K 0.34%
+80,000
New +$872K
MITA
82
DELISTED
Coliseum Acquisition Corp. Class A Ordinary Share
MITA
$827K 0.33%
85,000
– –
PEPG icon
83
PepGen
PEPG
$167M
$794K 0.32%
+80,000
New +$892K
RCOR
84
DELISTED
Renovacor, Inc.
RCOR
$788K 0.32%
388,845
– –
ANGO icon
85
AngioDynamics
ANGO
$625M
$767K 0.31%
+39,640
New +$812K
SDOT icon
86
Sadot Group
SDOT
$13.3M
$692K 0.28%
898
– –
LIAN
87
DELISTED
LianBio American Depositary Shares
LIAN
$681K 0.27%
+315,191
New +$1.07M
STOK icon
88
Stoke Therapeutics
STOK
$2.06B
$634K 0.25%
+48,000
New +$729K
LONA
89
CALL
LeonaBio Inc
LONA
$73.4M
$610K 0.24%
+20,010
New +$1.83M
DDI
90
DoubleDown Interactive
DDI
$590M
$588K 0.24%
60,876
– –
GERN icon
91
Geron
GERN
$1.01B
$576K 0.23%
+371,367
New +$525K
ALKS icon
92
Alkermes
ALKS
$8.11B
$536K 0.21%
+18,000
New +$517K
RLMD icon
93
Relmada Therapeutics
RLMD
$564M
$532K 0.21%
28,000
-178,000
-86% -$3.88M
GSRMU
94
DELISTED
GSR II Meteora Acquisition Corp. Unit
GSRMU
$499K 0.2%
50,000
– –
PSQH icon
95
PSQ Holdings
PSQH
$14.3M
$488K 0.2%
3,333
– –
SAGE
96
DELISTED
Sage Therapeutics
SAGE
$485K 0.19%
+15,000
New +$503K
SURGW
97
DELISTED
SurgePays, Inc. Warrant
SURGW
$300K 0.12%
250,000
– –
ZEV.WS
98
DELISTED
Lightning eMotors, Inc. Redeemable Warrants, each whole warrant exercisable 1/20th of a share of common stock at an exercise price of $230.00 per whole share
ZEV.WS
$255K 0.1%
652,173
– –
HCDIZ
99
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIZ
$244K 0.1%
650,000
– –
TCBPW
100
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
$223K 0.09%
941,176
– –
2 3
4
5 6

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return

Altium Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Altium Capital Management held 148 positions worth $250M, down 16% from $299M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Altium Capital Management's Q2 2022 filing shows 29 new, 17 increased, 14 reduced and 22 closed positions. Its largest new stake was PepperLime Health Acquisition Corporation Class A Ordinary Share: 735,000 shares worth $7.25M. The largest sale was Esperion Therapeutics, an estimated $7.56M.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 78% a quarter earlier, followed by Financials and Industrials.

  • Altium Capital Management's largest Q2 2022 buy was PepperLime Health Acquisition Corporation Class A Ordinary Share: 735,000 shares worth $7.25M.
  • Altium Capital Management added most to Lantheus in Q2 2022, an estimated $3.03M increase.
  • Altium Capital Management's biggest Q2 2022 reduction was Esperion Therapeutics, cutting an estimated $7.56M.
  • Altium Capital Management fully exited PepperLime Health Acquisition Corporation Unit in Q2 2022, selling an estimated $7.23M.
  • Altium Capital Management's ten largest holdings make up 27% of its $250M portfolio in Q2 2022.
  • Altium Capital Management opened 29 new positions and closed 22 in Q2 2022.
  • Altium Capital Management's portfolio value fell 16% quarter-over-quarter to $250M.

Based on Altium Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.